Price Alert

RVL Pharmaceuticals (OSMT)

NASDAQ: OSMT · Real-Time Price · USD

1.11

-0.02 (-1.77%)

At close: Jan 19, 2022, 6:00 AM

RVL Pharmaceuticals Statistics

Share Statistics

RVL Pharmaceuticals has 99.26M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	99.26M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	33.68M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 241.35K, so 0% of the outstanding shares have been sold short.

Short Interest	241.35K
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -1.95 and the forward PE ratio is null. RVL Pharmaceuticals's PEG ratio is 0.04.

PE Ratio	-1.95
Forward PE	n/a
PS Ratio	2.02
Forward PS	n/a
PB Ratio	1.97
P/FCF Ratio	-2.61
PEG Ratio	0.04

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for RVL Pharmaceuticals.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.13.

Current Ratio	2.89
Quick Ratio	2.85
Debt / Equity	1.13
Debt / EBITDA	-1.59
Debt / FCF	-1.49
Interest Coverage	-14.69

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$164.64K
Profits Per Employee	$-171.17K
Employee Count	302
Asset Turnover	0.39
Inventory Turnover	12.06

Taxes

Income Tax	-20K
Effective Tax Rate	0.04%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.96, so RVL Pharmaceuticals's price volatility has been higher than the market average.

Beta	1.96
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	594,359

Income Statement

In the last 12 months, RVL Pharmaceuticals had revenue of 49.72M and earned -51.69M in profits. Earnings per share was -0.58.

Revenue	49.72M
Gross Profit	40.27M
Operating Income	-45.68M
Net Income	-51.69M
EBITDA	-36.19M
EBIT	-48.6M
Earnings Per Share (EPS)	-0.58

Full Income Statement

Balance Sheet

The company has 44.54M in cash and 57.49M in debt, giving a net cash position of -12.95M.

Cash & Cash Equivalents	44.54M
Total Debt	57.49M
Net Cash	-12.95M
Retained Earnings	-569.22M
Total Assets	109.55M
Working Capital	-30.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.81M and capital expenditures -752K, giving a free cash flow of -38.56M.

Operating Cash Flow	-37.81M
Capital Expenditures	-752K
Free Cash Flow	-38.56M
FCF Per Share	-0.43

Full Cash Flow Statement

Margins

Gross margin is 80.98%, with operating and profit margins of -91.87% and -103.96%.

Gross Margin	80.98%
Operating Margin	-91.87%
Pretax Margin	-104%
Profit Margin	-103.96%
EBITDA Margin	-72.78%
EBIT Margin	-91.87%
FCF Margin	-77.56%

Dividends & Yields

OSMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for OSMT.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-8.16
Piotroski F-Score	3